Julian R Molina, MD, PhD

  • 7964 Citations
  • 36 Scopus h-Index
19962019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Julian R Molina is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Pemetrexed Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 7964 Citations
  • 36 Scopus h-Index
  • 109 Article
  • 1 Chapter
  • 1 Editorial
  • 1 Review article
1 Citation (Scopus)

Non–Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment

Duma, N., Santana-Davila, R. & Molina, J. R., Aug 1 2019, In : Mayo Clinic proceedings. 94, 8, p. 1623-1640 18 p.

Research output: Contribution to journalReview article

Open Access
Early Detection of Cancer
Non-Small Cell Lung Carcinoma
Programmed Cell Death 1 Receptor
Epidemiology
Lung Neoplasms
1 Citation (Scopus)

PFKFB3 inhibition reprograms malignant pleural mesothelioma to nutrient stress-induced macropinocytosis and ER stress as independent binary adaptive responses

Sarkar Bhattacharya, S., Thirusangu, P., Jin, L., Roy, D., Jung, D., Xiao, Y., Staub, J., Roy, B., Molina, J. R. & Shridhar, V., Oct 1 2019, In : Cell Death and Disease. 10, 10, 725.

Research output: Contribution to journalArticle

Open Access
Phosphofructokinase-2
Endoplasmic Reticulum Stress
Fructose
Food
Cell Death
20 Citations (Scopus)

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L. C., Halfdanarson, T. R., Grothey, A. F., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jan 1 2019, In : JAMA Oncology.

Research output: Contribution to journalArticle

CD274 Antigen
Meta-Analysis
Clinical Trials
Incidence
Odds Ratio
11 Citations (Scopus)

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: An updated analysis of keynote-010 trial

Herbst, R. S., Baas, P., Perez-Gracia, J. L., Felip, E., Kim, D. W., Han, J. Y., Molina, J. R., Kim, J. H., Dubos Arvis, C., Ahn, M. J., Majem, M., Fidler, M. J., Surmont, V., De Castro, G., Garrido, M., Shentu, Y., Emancipator, K., Samkari, A., Jensen, E. H., Lubiniecki, G. M. & 1 others, Garon, E. B., Feb 1 2019, In : Annals of Oncology. 30, 2, p. 281-289 9 p.

Research output: Contribution to journalArticle

docetaxel
Confidence Intervals
Survival
Neoplasms
Proteins
tipifarnib
Farnesyltranstransferase
Epidermal Growth Factor
Protein-Tyrosine Kinases
Maximum Tolerated Dose